N-(4-Chloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-2-yl)pivalamide

Catalog No. :
ACZPKR607
CAS No. :
149765-16-2
Molecular Formula :
C11H12ClIN4O
Molecular Weight :
378.60

IUPAC Name:N-(4-chloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-2-yl)pivalamide

N-(4-Chloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-2-yl)pivalamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$65.00Login to see priceIn stockIn stock
5g95%$267.00Login to see priceIn stockIn stock
25g95%$1268.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(4-Chloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-2-yl)pivalamide
IUPAC NameN-(4-chloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-2-yl)pivalamide
MDL No.MFCD11109808
Molecular FormulaC11H12ClIN4O
Molecular Weight378.60
SMILESClC1=NC(=NC2=C1C(=C[NH]2)I)NC(C(C)(C)C)=O
InChI KeyKZDHRXDFCHHFEJ-UHFFFAOYSA-N
Synonym149765-16-2 | N-(4-Chloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-2-yl)-2,2-dimethylpropionamide | N-(4-chloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-2-yl)pivalamide | N-(4-chloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-2-yl)-2,2-dimethylpropanamide | Propanamide, N-(4-chloro-5-i
CAS No.149765-16-2
PubChem CID15484841

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACZPKR607 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOYCE239 route compound structure diagram
    ACOYCE239149765-15-1 In Stock
  2. Then
  3. ACZPKR607 route product structure diagram
    ACZPKR607149765-16-2 In Stock
Inquiry

2. ACZPKR607 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOYCE239 route compound structure diagram
    ACOYCE239149765-15-1 In Stock
  2. Then
  3. ACZPKR607 route product structure diagram
    ACZPKR607149765-16-2 In Stock
Inquiry

Comments (0)